• Հայերեն
  • Русский
  • English
pharm.am
  • Home
  • About us
  • Main Functions
  • News and Announcements
  • Publications
  • Veterinary medicines
  • Contacts

Dear Healthcare Professional Letter

Important information on Dacarbazine medac 200 mg: decreased stability after reconstitution
Leuprorelin-containing depot products: need to strictly follow instructions for reconstitution and administration to reduce the risk of handling errors that may result in lack of efficacy
5-Fluorouracil (i.v.), capecitabine and tegafur containing products
The risk of birth defects from the recently published epidemiological studies for Zofran (Ondansetron)
New important information on safety of medicine Esmya, 5 mg tablets
Domperidone-containing products: reminder of indication and contraindications related to serious cardiac side efefcts
Methotrexate
Kadcyla: HCP Educational Information
Tecentriq (atezolizumab)
Actemra (tocilizumab)

Page 4 of 7

  • 1
  • 2
  • 3
  • 4
  • ...
  • 6
  • 7
  • Register of medicinal products
  • Guide to using "Register of medicinal products"
  • Drugs safety profile
  • ONLINE report about adverse effect of medicine
  • Whistle-blowing

PUBLICATIONS

  • "Drugs and Medicines" Information Bulletin
  • “Safety of drugs” information leaflet
  • Dear Healthcare Professional Letter
  • Booklets
  • Dictionary

  • RSS
  • Facebook
  • Twitter
  • Home
  • About us
  • Main Functions
  • Committees and Councils
  • News and Announcements
  • Publications
  • Veterinary drugs
  • Contacts
  • SiteMap

Back to Top

© 2025 pharm.am